GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitro International (OTCPK:IVRO) » Definitions » YoY EBITDA Growth

Invitro International (Invitro International) YoY EBITDA Growth : 58.62% (As of Jun. 2097)


View and export this data going back to 1991. Start your Free Trial

What is Invitro International YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Invitro International's YoY EBITDA Growth for the quarter that ended in Jun. 2097 was 58.62%.

Invitro International's EBITDA per Share for the three months ended in Jun. 2097 was $-0.01.

Invitro International YoY EBITDA Growth Historical Data

The historical data trend for Invitro International's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invitro International YoY EBITDA Growth Chart

Invitro International Annual Data
Trend Feb90 Feb91 Sep92 Sep93 Sep94 Sep95 Sep96
YoY EBITDA Growth
Get a 7-Day Free Trial -1,766.67 48.80 27.54 38.01 38.26

Invitro International Quarterly Data
Sep92 Dec92 Mar93 Jun93 Sep93 Dec93 Mar94 Jun94 Sep94 Dec94 Mar95 Jun95 Sep95 Dec95 Mar96 Jun96 Sep96 Dec96 Mar97 Jun97
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -196.67 84.86 150.00 23.68 58.62

Invitro International YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Invitro International's YoY EBITDA Growth for the fiscal year that ended in Sep. 2096 is calculated as:

YoY EBITDA Growth (A: Sep. 2096 )
=(EBITDA per Share (A: Sep. 2096 )-EBITDA per Share (A: Sep. 2095 ))/ | EBITDA per Share (A: Sep. 2095 ) |
=(-0.142--0.23)/ | -0.23 |
=38.26 %

Invitro International's YoY EBITDA Growth for the quarter that ended in Jun. 2097 is calculated as:

YoY EBITDA Growth (Q: Jun. 2097 )
=(EBITDA per Share (Q: Jun. 2097 )-EBITDA per Share (Q: Jun. 2096 )) / | EBITDA per Share (Q: Jun. 2096 )) |
=(-0.012--0.029)/ | -0.029 |
=58.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invitro International YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Invitro International's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Invitro International (Invitro International) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitro International (OTCPK:IVRO) » Definitions » YoY EBITDA Growth
Comparable Companies
ASX:LSH IDTA TSXV:TELO ASX:CTE XSAT:ALPH BOM:526301 ABMC BOM:541299 BOM:526546 NGM:LIFE B XLRM TSXV:AVCR TEAR WAR:BMX XKRX:271850 TSXV:MBI.H WAR:IGN BOM:526504 BOM:516110 SGX:505
Traded in Other Exchanges
N/A
Address
330 East Orangethorpe Avenue, Suite D, Placentia, CA, USA, 92870
Website
https://www.invitrointl.com
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.